Priming BCL-2 to kill: the combination therapy of tamoxifen and ABT-199 in ER+ breast cancer (Q33745649)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Priming BCL-2 to kill: the combination therapy of tamoxifen and ABT-199 in ER+ breast cancer
scientific article

    Statements

    Priming BCL-2 to kill: the combination therapy of tamoxifen and ABT-199 in ER+ breast cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit